A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression

@article{Erickson2016AMO,
  title={A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression},
  author={Molly A. Erickson and Abigail Ruffle and James M. Gold},
  journal={Biological Psychiatry},
  year={2016},
  volume={79},
  pages={980-987}
}
BACKGROUND The observation that mismatch negativity (MMN) is consistently impaired in schizophrenia has generated considerable interest in the use of this biomarker as an index of disease risk and progression. Despite such enthusiasm, a number of issues remain unresolved regarding the nature of MMN impairment. The present study expands upon an earlier meta-analysis of MMN impairment in schizophrenia by examining impairment across a range of clinical presentations, as well as across experimental… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

Electrophysiological Endophenotypes for Schizophrenia.

Harvard review of psychiatry • 2016
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…